FDA Approved: IRINOTECAN HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approves Hospira's supplemental application for irinotecan hydrochloride (ANDA 077915), enabling the marketed generic product. This action completes the sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

SUPPL AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)